COMPARISON OF HISTIDINE-TRYPTOPHAN-KETOGLUTARATE (HTK) SOLUTION VERSUS UNIVERSITY-OF-WISCONSIN (UW) SOLUTION FOR ORGAN PRESERVATION IN HUMAN LIVER-TRANSPLANTATION - A PROSPECTIVE, RANDOMIZED STUDY

被引：44

作者：

ERHARD, J

LANGE, R

SCHERER, R

KOX, WJ

BRETSCHNEIDER, HJ

GEBHARD, MM

EIGLER, FW

机构：

[1] Abteilung für Allgemeine Chirurgie, Universitätsklinikum, Essen, D-45147

[2] Institut für Anästhesie, Universitätsklinikum, Essen, D-45147

[3] Institut für Physiologie, Universität Göttingen, Göttingen, D-37073

来源：

TRANSPLANT INTERNATIONAL | 1994年 / 7卷 / 03期

关键词：

HTK SOLUTION; UW SOLUTION; LIVER PRESERVATION LIVER TRANSPLANTATION;

D O I：

10.1007/BF00327084

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Over a 30-month period. 60 patients (30 in each group) suffering from end-stage liver disease or primary hepatic malignancy and scheduled for liver transplantation were enrolled in a prospective. randomized study to compare two methods of liver preservation: histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution. Entry criteria for both groups were: age (18-65 years), elective surgery (transplantable or urgent category of the recipients), first transplantations and harvesting procedure performed by the same team. The parameters under investigation were the clinical and laboratory data pre- and post-transplantation, as well as follow-up data such as complications and survival. There were no significant differences in the two groups as far as the evaluation criteria were concerned, even when cold ischemia time was more than 15 h (n = 7). A slight, yet not significant, increase in late complications of the biliary anastomoses could be seen in the UW group. Hepatocellular injury (SGOT, SGPT, GLDH, lactate) appeared to be more marked in the HTK group. These results suggest that both HTK and UW solutions are appropriate for clinical use in liver transplantation, even if cold ischemia time is more than 15 h.

引用

页码：177 / 181

页数：5

共 14 条

[1] Belzer F.O., D'Alessandro A., Hoffman R.M., Knechtle S.J., Reed A., Pirch J.D., Kalayoglu M., Sollinger H.W., The use of UW solution in clinical transplantation, Ann Surg, 215, pp. 579-585, (1992)
[2] Bretschneider H.J., Myocardial protection, Thorac cardiovasc Surg, 28, pp. 295-302, (1980)
[3] Bretschneider H.J., Helmchen U., Kehrer G., Nierenprotektion, Klin Wochenschr, 66, pp. 817-827, (1988)
[4] Colonna J.O., Shaked A., Gomes A.S., Colquhoun S.D., Jurim O., McDiarmid S.V., Millis J.M., Goldstein L.I., Busuttil R.W., Biliary strictures complicating liver transplantation, Ann Surg, 216, pp. 344-352, (1992)
[5] Erhard J., Lange R., Niebel W., Scherer R., Donhuijsen K., Zotz R., Eigler F.W., Results of experimental liver transplantation in the minipig with HTK preserved organs, Experimental and clinical liver transplantation, pp. 93-99, (1991)
[6] Erhard J., Lange R., Scherer R., Eigler F., Experiences with histidin-tryptophan-ketoglutarat (HTK)-perfused organs in clinical liver transplantation, Transplant Proc, 25, pp. 1885-1886, (1993)
[7] Gubernatis G., Abendroth D., Haverich A., Bunzendahl H., Illner W.D., Meyer H-J, Land W., Pichlmayr R., Technik der Mehrorganentnahme, Chirurg, 59, pp. 461-467, (1988)
[8] Gubernatis G., Pichlmayr R., Lamesch P., Grosse H., Bornscheuer A., Meyer H-J, Ringe B., Farle M., Bretschneider H.J., HTK-solution (Bretschneider) for human liver transplantation, Langenbecks Arch Chir, 375, pp. 66-70, (1990)
[9] Gubernatis G., Dietl K-H, Kemnitz J., Oldhafer J., Hauss J., Buchholz B., Pichlmayr R., Extended cold preservation time (20 hours 20 minutes) of a human liver graft by using cardioplegic HTK solution, Transplant Proc, 23, pp. 2408-2409, (1991)
[10] Holscher M., Groenewoud A.F., Current status of the HTK solution of Bretschneider in organ preservation, Transplant Proc, 23, pp. 2334-2337, (1991)

← 1 2 →